Adenylosuccinic acid: a novel inducer of the cytoprotectant Nrf2 with efficacy in Duchenne muscular dystrophy.


Journal

Current medical research and opinion
ISSN: 1473-4877
Titre abrégé: Curr Med Res Opin
Pays: England
ID NLM: 0351014

Informations de publication

Date de publication:
03 2021
Historique:
pubmed: 18 12 2020
medline: 16 10 2021
entrez: 17 12 2020
Statut: ppublish

Résumé

Adenylosuccinic acid (ASA) modifies Duchenne muscular dystrophy (DMD) progression in dystrophic

Identifiants

pubmed: 33331789
doi: 10.1080/03007995.2020.1865699
doi:

Substances chimiques

NF-E2-Related Factor 2 0
adenylosuccinate 19240-42-7
Adenosine Monophosphate 415SHH325A

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

465-467

Auteurs

Emma Rybalka (E)

Institute for Health and Sport, Victoria University, Melbourne, Australia.
Australian Institute for Musculoskeletal Science, Victoria University, St Albans, Australia.

Craig A Goodman (CA)

Australian Institute for Musculoskeletal Science, Victoria University, St Albans, Australia.
Center for Muscle Research, Department of Physiology, The University of Melbourne, Parkville, Australia.

Dean G Campelj (DG)

Institute for Health and Sport, Victoria University, Melbourne, Australia.
Australian Institute for Musculoskeletal Science, Victoria University, St Albans, Australia.

Alan Hayes (A)

Institute for Health and Sport, Victoria University, Melbourne, Australia.
Australian Institute for Musculoskeletal Science, Victoria University, St Albans, Australia.
Department of Medicine, Western Health, Melbourne Medical School, The University of Melbourne, Melbourne, Australia.

Cara A Timpani (CA)

Institute for Health and Sport, Victoria University, Melbourne, Australia.
Australian Institute for Musculoskeletal Science, Victoria University, St Albans, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH